Experience of immunotherapy treatment for non-small cell lung cancer within University Hospitals Leicester in patients treated both within and outside of a clinical trial

被引：0
|
作者：
Walter, H. S. [1 ]
Dickens, E. [1 ]
Muhammad, S. Ul-Islam [1 ]
Sridhar, T. [1 ]
Fennell, D. [2 ]
Ahmed, S. [3 ]
机构：
[1] Univ Hosp Leicester, Med Oncol, Leicester, Leics, England
[2] Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Leicester, Leics, England
[3] Univ Hosp Leicester NHS Trust, Med Oncol, Leicester, Leics, England
来源：
LUNG CANCER | 2018年 / 115卷
关键词：
D O I：
10.1016/S0169-5002(18)30124-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] Experience of multiple lines of systemic therapy in non-small cell lung cancer (NSCLC) at University Hospitals of Leicester
    Plant, R.
    Ahmed, S. I.
    Dahya, S.
    LUNG CANCER, 2013, 79 : S15 - S15
  • [2] Recruitment and outcome of lung cancer patients to clinical trials within the Department of Medical Oncology at University Hospitals Leicester
    Aoun, M. R. Abi
    Walter, H. S.
    Dickens, E.
    Mahgoub, M. O.
    Varadhan, B.
    Porter, S.
    Sridhar, T.
    Fennell, D.
    Ahmed, S.
    LUNG CANCER, 2018, 115 : S43 - S44
  • [3] DIFFERENT OUTCOMES IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) TREATED WITHIN OR OUTSIDE CONTROLLED CLINICAL TRIALS
    Rovere, Giulia
    Vavala, Tiziana
    Longo, Marina
    Pessina, Paolo
    Capelletto, Enrica
    Demichelis, Sara
    Rapetti, Simonetta G.
    Crida, Benedetta
    Novello, Silvia
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1187 - S1188
  • [4] What Lies Within: Novel Strategies in Immunotherapy for Non-Small Cell Lung Cancer
    Forde, Patrick M.
    Reiss, Kim A.
    Zeidan, Amer M.
    Brahmer, Julie R.
    ONCOLOGIST, 2013, 18 (11): : 1203 - 1213
  • [5] Markers of efficacy in patients treated with immunotherapy for non-small cell lung cancer: a single cancer centre experience
    Sallam, Mostafa
    Haque, Farzana
    Mirza, Shagufta
    Brown, Victoria
    Lind, Michael
    Pillai, Annet
    LUNG CANCER, 2021, 156 : S38 - S39
  • [6] Immunotherapy in the treatment of non-small cell lung cancer
    Sundar, Raghav
    Soong, Richie
    Cho, Byoung-Chul
    Brahmer, Julie R.
    Soo, Ross A.
    LUNG CANCER, 2014, 85 (02) : 101 - 109
  • [7] Obesity Paradox in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy
    Sanchez, Alejandro
    Furberg, Helena
    JAMA ONCOLOGY, 2020, 6 (06) : 940 - +
  • [8] Survival data and toxicity profile in advanced non-small cell lung cancer (NSCLC) patients (PTS) treated within or outside controlled clinical trials.
    Vavala, Tiziana
    Rovere, Giulia
    Rapetti, Simonetta
    Capelletto, Enrica
    Longo, Marina
    Levra, Matteo Giaj
    Crida, Benedetta
    Novello, Silvia
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Experience with osimertinib in second-line treatment of non-small cell lung cancer at Nottingham University Hospitals
    Sadiq, M.
    Khan, S.
    Lopez-Escola, C.
    Arora, A.
    Hennig, I.
    Abdallah, S.
    Soomro, I.
    LUNG CANCER, 2020, 139 : S62 - S62
  • [10] Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience
    Greillier, Laurent
    Tomasini, Pascale
    Barlesi, Fabrice
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (05) : 485 - 491
12345